Essex Bio-Technology (HK:1061) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Essex Bio-Technology Limited reported a decrease in turnover and profit for the first half of 2024 compared to the same period in 2023, with turnover down by 9.8% and profit by 7.3%. Despite the downturn, the company’s total assets and net assets increased by 4.9% and 4.8% respectively, and it raised its interim dividend from HK4.5 cents to HK6.0 cents per ordinary share. Financial ratios such as gross profit margin and net profit margin showed slight variations, indicating changes in profitability and efficiency.
For further insights into HK:1061 stock, check out TipRanks’ Stock Analysis page.